ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.09
-0.24 (-3.21%)
At close: Nov 18, 2025, 4:00 PM EST
7.25
+0.16 (2.31%)
Pre-market: Nov 19, 2025, 8:59 AM EST
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $700.34 million as of November 19, 2025. Its market cap has decreased by -50.92% in one year.
Market Cap
700.34M
Enterprise Value
581.94M
1-Year Change
-50.92%
Ranking
Category
Stock Price
$7.09
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $700.34M, an increase of 23.25%. That is a compound annual growth rate of 7.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 723.57M | -29.43% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |